At a time when the world is facing a corona epidemic. The big biopharmaceutical company Biocon's vaccine has been approved to be used in the treatment of epidemic. The company will soon introduce this vaccine. Hetero Healthcare Limited has stated that it will produce 60 thousand bottles of generic injection of ramdesvir in India between 13 to 20 July.

Koviphor is the first vaccine of Remedesvir's generic brand. It is used in the treatment of children, adults, and patients with severe symptoms infected with Covid-19. It is available in 100 mg vial.

In a special interaction with the media, the company's chairperson Kiran Mazumdar-Shaw said that the Controller General of India (DCGI) has given permission to the company for its marketing. It will be used to treat patients with moderate to severe symptoms. The price of a vial of 25 mg / five mL of the company's vaccine Itolizumab has been fixed at Rs 7,950. This vaccine was introduced in 2013 for the treatment of chronic plaque psoriasis. The company tested the vaccine in Mumbai, the capital, and Cuba. Based on its results, it has been approved to bring this vaccine. Shaw said that many states have demanded this vaccine because doctors here have saved many lives by using this vaccine.

Also Read-

Flood in Assam become reason for destruction of people's lives

Floods wreaked havoc in Bihar, rescue teams reached

IIT Kanpur's new invention 'Padmavati' will reveal purity of water